GeoVax Labs, Inc.

GOVX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-3.3M
Depreciation & Amortization $89.8K
Depreciation —
Amortization —
Stock-Based Compensation $1.3M
Net Cash from Operating Activities $-1.4M
Investing Activities
Capital Expenditures $270.2K
Business Acquisitions —
Net Cash from Investing Activities $-270.2K
Financing Activities
Dividends Paid —
Stock Repurchases —
Net Cash from Financing Activities $3.0M
Net Change in Cash $1.3M
Free Cash Flow $-1.7M
← Newer Page 3 of 3 Older →